Kaneka Corporation (TYO:4118)
Japan · Delayed Price · Currency is JPY | Market Cap | 306.44B +40.2% |
| Revenue (ttm) | 811.64B +0.6% |
| Net Income | 30.98B +22.4% |
| EPS | 499.47 +25.0% |
| Shares Out | 57.23M |
| PE Ratio | 10.72 |
| Forward PE | 11.65 |
| Dividend | 160.00 (3.00%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 87,900 |
| Average Volume | 240,095 |
| Open | 5,360.00 |
| Previous Close | 5,355.00 |
| Day's Range | 5,306.00 - 5,412.00 |
| 52-Week Range | 3,715.00 - 5,502.00 |
| Beta | 0.31 |
| RSI | 63.99 |
| Earnings Date | May 14, 2026 |
About Kaneka
Kaneka Corporation engages in the manufacture and sale of polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan and internationally. It provides impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, and biodegradable polymer, as well as engineering resin for injection molding, acrylic film, and isobutylene-based thermoplastic elastomer produ... [Read more]
Financial Performance
In fiscal year 2026, Kaneka's revenue was 811.64 billion, an increase of 0.55% compared to the previous year's 807.20 billion. Earnings were 30.98 billion, an increase of 22.40%.
Financial StatementsNews
Kaneka Medical America LLC Announces U.S. Launch of WaveSelect 1014 Guidewire
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kaneka Medical America LLC , a subsidiary company of Kaneka Corporation , innovating embolization coil technology for neurovascular therapies, today announc...